Test Price
2,800 AED✅ Home Collection Available
PDHA1 Gene Pyruvate Dehydrogenase E1-Alpha Deficiency Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين PDHA1 لنقص إنزيم بيروفات ديهيدروجينيز E1-alpha في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Interpretation by DHA-Licensed Experts.
- Insurance: Direct Billing Verification – WhatsApp +971 54 548 8731.
ملخص تنفيذي: اختبار جيني متقدم بتقنية التسلسل الجيني من الجيل التالي (NGS) لتشخيص نقص إنزيم بيروفات ديهيدروجينيز المرتبط بجين PDHA1، معتمد من هيئة الصحة بدبي وفق أعلى معايير الدقة والخصوصية القانونية في دولة الإمارات العربية المتحدة. يُجرى التحليل على عينة دم أو حمض نووي مستخلص مع استشارة وراثية إلزامية، وتظهر النتائج خلال 3-4 أسابيع بتكلفة 2800 درهم.
Test Overview
The PDHA1 Gene Pyruvate Dehydrogenase E1-Alpha Deficiency NGS Test is a definitive molecular assay designed to detect pathogenic variants in the PDHA1 gene, the genetic cause of pyruvate dehydrogenase complex deficiency—a severe metabolic disorder affecting the nervous system and energy metabolism. This UAE-based, DHA-compliant analysis uses next-generation sequencing (NGS) to guarantee complete coverage of the gene’s coding regions with >99.9% diagnostic sensitivity, delivering life-altering clinical clarity for affected families and guiding precision management. يوفر هذا الفحص تشخيصًا جزيئيًا دقيقًا وموثوقًا يتوافق مع أعلى البروتوكولات الطبية في الإمارات.
| Feature | Our Test (PDHA1 NGS) | Closest Alternative |
|---|---|---|
| Methodology | Full Gene NGS + CNV Analysis | Biochemical Lactate/Pyruvate Ratio |
| Genetic Coverage | 100% Coding Exons + Splice Sites | No genetic data; only metabolic snapshot |
| Turnaround Time | 3–4 Weeks | 1–2 Days (but not confirmatory) |
| Regulatory Compliance | DHA & UAE Genetic Testing Law 41/2024 | Standard laboratory accreditation |
| Clinical Utility | Definitive diagnosis, family screening, prognosis | Suggestive but non‑diagnostic |
Physician Insight & Safety Protocol
“Every PDHA1 test result tells a unique story of energy failure and neurological vulnerability. I always interpret this genetic finding alongside the patient’s clinical picture, because the same mutation can present with profound neonatal lactic acidosis or with subtle movement disorders later in life. This test is not just a lab value; it’s the beginning of a lifelong care journey.”
– Dr. PRABHAKAR REDDY, DHA License 61713011, Clinical Biochemist & Metabolic Specialist
🛑 Medication Warning: Do not discontinue any prescribed medication, especially anti‑epileptics or metabolic supplements, without prior physician approval. Abrupt changes can trigger severe metabolic crises.
Safety Exclusion Criteria & Emergency Red Flags
- Active acute illness with hemodynamic instability – postpone collection.
- Test cannot be performed on neonates < 34 weeks corrected age without NICU clearance.
- Genetic testing of asymptomatic minors is regulated under UAE CDS Law 2026; prior ethics committee approval may be required.
- If the patient experiences sudden severe lethargy, intractable seizures, or respiratory distress, seek immediate emergency medical attention regardless of test status.
Who Orders This Test? (Top 3 Specialists)
General Physician
First‑line clinical suspicion of mitochondrial disorder in children with developmental delay, hypotonia, and lactic acidosis. Initiates diagnostic workup and coordinates with specialists.
Anti‑Aging Specialist
Evaluates PDHA1 variants in adults presenting with unexplained fatigue, exercise intolerance, or metabolic inflexibility; used to tailor mitochondrial support protocols.
Medical & PhD Researcher
For translational research on pyruvate dehydrogenase complex, genotype‑phenotype correlation, and enrollment in gene therapy trials.
Frequently Asked Questions
1. What does the PDHA1 NGS test detect and how accurate is it?
This test identifies single nucleotide variants, small insertions/deletions, and copy number changes across the entire PDHA1 gene with >99.9% analytical sensitivity, making it the most comprehensive diagnostic tool for pyruvate dehydrogenase E1-alpha deficiency. يكشف هذا الفحص الطفرات الجينية الشاملة في جين PDHA1 بحساسية تشخيصية تفوق 99.9%، مما يوفر تشخيصًا دقيقًا لنقص الإنزيم.
2. What sample types are accepted and is home collection available?
We accept whole blood, extracted DNA, or a single drop of blood on an FTA card; our VIP mobile phlebotomy team provides hospital‑grade home collection across all emirates with ISO‑certified cold‑chain transport, ensuring sample integrity from doorstep to lab. نقبل عينة الدم الكامل أو الحمض النووي المستخلص أو قطرة دم على بطاقة FTA، ونوفر خدمة السحب المنزلي الفندقي المتنقل والمعتمد من الآيزو لضمان جودة العينة.
3. How long does it take to receive results and what support is provided afterward?
Results are ready within 3–4 weeks and include a detailed molecular report; every patient receives a complimentary telephonic post‑ consultation with a DHA‑licensed clinician to explain findings and guide next steps in management or family testing. تصدر النتائج خلال 3-4 أسابيع مع تقرير جزيئي مفصل، ويحصل كل مريض على استشارة هاتفية مجانية بعد الفحص مع طبيب مرخص من هيئة الصحة بدبي لشرح النتائج وتوجيه الخطوات التالية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians